$137.24
00.00%
Pre-Market: 4:05 PM EDT
15 minutes delayed
Hamilton Lane
HLNENASDAQ
Hamilton Lane (NASDAQ:HLNE) Stock, Analyst Ratings, Price Targets, Forecasts
Hamilton Lane Inc has a consensus price target of $116.86 based on the ratings of 8 analysts. The high is $135 issued by Keefe, Bruyette & Woods on May 24, 2024. The low is $89 issued by Goldman Sachs on August 3, 2023. The 3 most-recent analyst ratings were released by UBS, JP Morgan, and Keefe, Bruyette & Woods on June 24, 2024, May 24, 2024, and May 24, 2024, respectively. With an average price target of $125.67 between UBS, JP Morgan, and Keefe, Bruyette & Woods, there's an implied -8.43% downside for Hamilton Lane Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
UBS
JP Morgan
Keefe, Bruyette & Woods
JP Morgan
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Hamilton Lane
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2024 | Buy Now | -11.1% | UBS | Adam Beatty | $120 → $122 | Maintains | Neutral | Get Alert |
| 05/24/2024 | Buy Now | -12.56% | JP Morgan | Ken Worthington | $115 → $120 | Maintains | Neutral | Get Alert |
| 05/24/2024 | Buy Now | -1.63% | Keefe, Bruyette & Woods | Michael Brown | $118 → $135 | Maintains | Market Perform | Get Alert |
| 04/12/2024 | Buy Now | -12.56% | UBS | Adam Beatty | $118 → $120 | Maintains | Neutral | Get Alert |
| 04/11/2024 | Buy Now | -16.21% | JP Morgan | Kenneth Worthington | → $115 | Downgrade | Overweight → Neutral | Get Alert |
| 02/07/2024 | Buy Now | -19.12% | Wells Fargo | Finian O'Shea | $106 → $111 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | Buy Now | -8.19% | Morgan Stanley | Michael Cyprys | $102 → $126 | Maintains | Equal-Weight | Get Alert |
| 01/22/2024 | Buy Now | -22.76% | Wells Fargo | Finian O'Shea | $99 → $106 | Maintains | Equal-Weight | Get Alert |
| 01/11/2024 | Buy Now | — | Oppenheimer | Chris Kotowski | — | Downgrade | Outperform → Perform | Get Alert |
| 11/21/2023 | Buy Now | -25.68% | Morgan Stanley | Michael Cyprys | $95 → $102 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | -24.95% | JP Morgan | Kenneth Worthington | $102 → $103 | Maintains | Overweight | Get Alert |
| 11/08/2023 | Buy Now | -35.15% | Wells Fargo | Finian O'Shea | $88 → $89 | Maintains | Equal-Weight | Get Alert |
| 10/18/2023 | Buy Now | -30.78% | Morgan Stanley | Michael Cyprys | $89 → $95 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | -35.15% | Morgan Stanley | Michael Cyprys | $84 → $89 | Maintains | Equal-Weight | Get Alert |
| 08/03/2023 | Buy Now | -35.15% | Goldman Sachs | Alexander Blostein | $78 → $89 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | -25.68% | JP Morgan | Kenneth Worthington | $96 → $102 | Maintains | Overweight | Get Alert |
| 08/02/2023 | Buy Now | -35.15% | Goldman Sachs | Alexander Blostein | $78 → $89 | Maintains | Neutral | Get Alert |
| 08/02/2023 | Buy Now | -29.32% | Oppenheimer | Chris Kotowski | $93 → $97 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | -36.61% | Wells Fargo | Finian O'Shea | $77 → $87 | Maintains | Equal-Weight | Get Alert |
| 07/19/2023 | Buy Now | -35.88% | UBS | Adam Beatty | $75 → $88 | Maintains | Neutral | Get Alert |
| 07/18/2023 | Buy Now | -38.79% | Morgan Stanley | Michael Cyprys | $77 → $84 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | -43.89% | Wells Fargo | Finian O'Shea | $71 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/30/2023 | Buy Now | -43.89% | Morgan Stanley | Michael Cyprys | — | Maintains | Equal-Weight | Get Alert |
| 05/30/2023 | Buy Now | -41.71% | Keefe, Bruyette & Woods | Michael Brown | $81 → $80 | Reiterates | Market Perform → Market Perform | Get Alert |
| 05/26/2023 | Buy Now | -40.98% | JP Morgan | Kenneth Worthington | $85 → $81 | Maintains | Overweight | Get Alert |
| 05/26/2023 | Buy Now | -36.61% | Oppenheimer | Chris Kotowski | → $87 | Upgrade | Perform → Outperform | Get Alert |
| 05/26/2023 | Buy Now | -48.27% | Wells Fargo | Finian O'Shea | $73 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/26/2023 | Buy Now | -41.71% | Keefe, Bruyette & Woods | Michael Brown | $81 → $80 | Maintains | Market Perform | Get Alert |
| 04/18/2023 | Buy Now | -40.98% | Keefe, Bruyette & Woods | Michael Brown | $85 → $81 | Maintains | Market Perform | Get Alert |
| 03/15/2023 | Buy Now | -38.06% | JP Morgan | Kenneth Worthington | → $85 | Upgrade | Neutral → Overweight | Get Alert |
| 02/09/2023 | Buy Now | -41.71% | Goldman Sachs | Alexander Blostein | $70 → $80 | Maintains | Neutral | Get Alert |
| 02/09/2023 | Buy Now | -43.17% | Morgan Stanley | Michael Cyprys | $72 → $78 | Maintains | Equal-Weight | Get Alert |
| 02/08/2023 | Buy Now | -38.06% | JP Morgan | Ken Worthington | $86 → $85 | Maintains | Neutral | Get Alert |
| 02/08/2023 | Buy Now | -45.35% | Wells Fargo | Finian O'Shea | $69 → $75 | Maintains | Equal-Weight | Get Alert |
| 01/24/2023 | Buy Now | -47.54% | Morgan Stanley | Michael Cyprys | $67 → $72 | Maintains | Equal-Weight | Get Alert |
| 01/11/2023 | Buy Now | -49.72% | Wells Fargo | Finian O'Shea | $65 → $69 | Maintains | Equal-Weight | Get Alert |
| 10/19/2022 | Buy Now | -50.45% | UBS | Adam Beatty | $75 → $68 | Maintains | Neutral | Get Alert |
| 10/19/2022 | Buy Now | -51.18% | Morgan Stanley | Michael Cyprys | $72 → $67 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | -47.54% | Morgan Stanley | Michael Cyprys | $73 → $72 | Maintains | Equal-Weight | Get Alert |
| 08/09/2022 | Buy Now | -45.35% | UBS | Adam Beatty | $72 → $75 | Downgrade | Buy → Neutral | Get Alert |
| 07/19/2022 | Buy Now | -46.81% | Morgan Stanley | Michael Cyprys | $92 → $73 | Maintains | Equal-Weight | Get Alert |
| 07/13/2022 | Buy Now | -47.54% | Wells Fargo | Finian O'Shea | $74 → $72 | Maintains | Equal-Weight | Get Alert |
| 06/29/2022 | Buy Now | -44.62% | Goldman Sachs | Alexander Blostein | $85 → $76 | Maintains | Neutral | Get Alert |
| 06/01/2022 | Buy Now | -32.96% | Morgan Stanley | Michael Cyprys | $101 → $92 | Maintains | Equal-Weight | Get Alert |
| 04/20/2022 | Buy Now | -26.41% | Morgan Stanley | Michael Cyprys | $111 → $101 | Maintains | Equal-Weight | Get Alert |
| 04/19/2022 | Buy Now | -43.17% | Wells Fargo | Finian O'Shea | $95 → $78 | Maintains | Equal-Weight | Get Alert |
| 01/21/2022 | Buy Now | -19.12% | Morgan Stanley | Michael Cyprys | $120 → $111 | Maintains | Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | -20.58% | Wells Fargo | Finian O'Shea | — | Initiates | → Equal-Weight | Get Alert |
| 10/15/2021 | Buy Now | -26.41% | Morgan Stanley | Michael Cyprys | — | Maintains | Equal-Weight | Get Alert |
| 08/04/2021 | Buy Now | -28.59% | Morgan Stanley | Michael Cyprys | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Hamilton Lane (HLNE) stock?
The latest price target for Hamilton Lane (NASDAQ:HLNE) was reported by UBS on June 24, 2024. The analyst firm set a price target for $122.00 expecting HLNE to fall to within 12 months (a possible -11.10% downside). 21 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Hamilton Lane (HLNE)?
The latest analyst rating for Hamilton Lane (NASDAQ:HLNE) was provided by UBS, and Hamilton Lane maintained their neutral rating.
When was the last upgrade for Hamilton Lane (HLNE)?
The last upgrade for Hamilton Lane Inc happened on May 26, 2023 when Oppenheimer raised their price target to $87. Oppenheimer previously had a perform for Hamilton Lane Inc.
When was the last downgrade for Hamilton Lane (HLNE)?
The last downgrade for Hamilton Lane Inc happened on April 11, 2024 when JP Morgan changed their price target from N/A to $115 for Hamilton Lane Inc.
When is the next analyst rating going to be posted or updated for Hamilton Lane (HLNE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hamilton Lane, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hamilton Lane was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
Is the Analyst Rating Hamilton Lane (HLNE) correct?
While ratings are subjective and will change, the latest Hamilton Lane (HLNE) rating was a maintained with a price target of $120.00 to $122.00. The current price Hamilton Lane (HLNE) is trading at is $137.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.